Delivery Order SPE2DB20D1109-SPE2DB25FN02P

Award Date 11/2/24
Potential Completion Date 11/4/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,108.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOOSTRIX TDAP vaccine syringes, a critical pharmaceutical product used to support military and government healthcare programs. The firm-fixed-price delivery order has a ceiling value of $2,554.30 and an ultimate completion date of September 19, 2024. This award is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of November 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product. This is a firm fixed-price delivery order contract with a completion date of December 3, 2024. Amerisourcebergen, as the prime contractor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,062.24, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This appears to be a one-time Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC enables the DLA to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BOOSTRIX TDAP vaccines in 0.5 mL syringes. The $5,499.04 firm-fixed-price delivery order has an ultimate completion date of August 21, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,329.55 firm fixed-price delivery order is for the supply of the BOOSTRIX TDAP vaccine in 0.5 ml syringes. The contract has an ultimate completion date of December 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.15 Firm Fixed Price Delivery Order contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a critical vaccine product, with a completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.64 firm fixed price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a completion date of December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,938.68 firm-fixed-price delivery order is for the supply of 4,566,495,044 doses of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has an ultimate completion date of November 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN02P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,554.30, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there are no major subcontractors mentioned. The award date is November 2, 2024, with an ultimate completion date of November 4, 2024, and a firm fixed price pricing type.

Generated 2/27/25, 12:13 PM